Suppression of Melanoma Cell Proliferation by Histidine Decarboxylase Specific Antisense Oligonucleotides

This publication has 14 references indexed in Scilit:

• Histidine Decarboxylase Expression in Human Melanoma
  Journal of Investigative Dermatology, 2000
• Both interferon (IFN) α and IFN γ inhibit histidine decarboxylase expression in the HT168 human melanoma cell line
  Inflammation Research, 2000
• H2-antagonists in the treatment of colon and breast cancer
  Seminars in Cancer Biology, 2000
• H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells
  Seminars in Cancer Biology, 2000
• Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon γ in peripheral human blood mononuclear cells and in CD19-depleted cell subsets
  Immunology Letters, 1999
• Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions
  International Journal of Cancer, 1999
• Gene Therapy for Tumors of the Central Nervous System
  Surgical Oncology Clinics of North America, 1998
• Histamine as an autocrine growth factor in experimental mammary carcinomas
  Inflammation Research, 1994
• Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine)
  European Journal of Cancer and Clinical Oncology, 1988
• Histamine‐forming capacity of multiplying cells
  The Journal of Physiology, 1963